title: Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose.
authors.forename: S A
authors.initials: SA
authors.lastname: Van Meter
authors.forename: H
authors.initials: H
authors.lastname: Seaburg
authors.forename: B
authors.initials: B
authors.lastname: McLendon
authors.forename: P M
authors.initials: PM
authors.lastname: Doraiswamy
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D062787:Drug Overdose / Q000523:psychology*; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000506:poisoning*; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D012307:Risk Factors; D013406:Suicide, Attempted / Q000523:psychology*
chemical_list: D014150:Antipsychotic Agents; D007328:Insulin; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine